Biotebal Max 10 mg x 30 tabl.

Directions for use: Use as directed by your doctor
Detailed instructions for use can be found in the leaflet included in the package.

Storage: Store at ambient temperature

Biotin

Zakłady Farmaceutyczne Polpharma S.A.

Zakłady Farmaceutyczne Polpharma S.A.,
street Pelplińska 19,
83-200 Starogard Gdański,
EN

Impact on clinical laboratory testing. Biotin may interfere with laboratory tests based on the interaction of biotin and streptavidin, leading to falsely decreased or falsely increased test results, depending on the sample. The risk of effects is greater in children and patients with renal impairment and increases with higher doses. When interpreting laboratory test results, the possible influence of biotin should be taken into account, especially if there is no compliance with the clinical picture (e.g.thyroid test results imitating Graves' disease results in asymptomatic patients taking biotin or false negative troponin test results in patients with myocardial infarction taking biotin). In cases where an impact is suspected, alternative tests not affected by biotin should be performed, if available. If laboratory tests are ordered in patients taking biotin, laboratory personnel should be consulted. In order to minimize the impact of biotin on laboratory test results, the product should be discontinued 3 days before the planned test, unless the laboratory gives other recommendations in this regard. Children and youth. In children and adolescents, the medicinal product can only be used after prescription by a doctor. Special warnings regarding excipients. Lactose. Each tablet contains 107.8 mg of lactose monohydrate. This medicinal product should not be used in patients with rare hereditary problems of galactose intolerance, the total lactase deficiency or glucose-galactose malabsorption. The medicinal product contains less than 1 mmol (23 mg) sodium per tablet per tablet, i.e. the product is essentially 'sodium-free'.